Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04245111 · ClinicalTrials.gov registry record
ICG Fluorescence Imaging in Trauma Patients
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 20
- Enrollment target
NCT04245111 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT04245111 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This will be a prospective observational trial to better understand the range and variation associated with bone/soft tissue perfusion in fracture patients and examine the relationship between perfusion, measured using quantitative Indocyanine green (ICG) fluorescence and complications such as surgical site infection (SSI), persistent SSI, and fracture nonunion.
Interventions
- OTHER Immunofluorescence Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-05-16 |
| Est. Completion | 2022-11-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04245111
The ClinicalTrials.gov registry entry for NCT04245111 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Immunofluorescence Imaging is the first listed.
NCT04245111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04245111 about?
NCT04245111 is a clinical study titled "ICG Fluorescence Imaging in Trauma Patients". This will be a prospective observational trial to better understand the range and variation associated with bone/soft tissue perfusion in fracture patients and examine the relationship between perfusion, measured using quantitative Indocyanine green (ICG) fluorescence and complications such as surgi...
What is the current status of trial NCT04245111?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2019-05-16. Estimated completion is 2022-11-18.
What interventions are being tested in trial NCT04245111?
The interventions under investigation include: Immunofluorescence Imaging (OTHER).
Who is sponsoring clinical trial NCT04245111?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.